Slow Q1 For Baxter, But Board Remains Confident Of Turnaround
Baxter International recorded slight revenue increases during quarter one of 2021, with sales still impacted by COVID-19. Its board remains optimistic , pointing towards new product releases and “operational strength” as redeeming factors.
You may also be interested in...
The company stopped shipping Alaris in early 2020 after the FDA requested a new 510(k) for modifications and the device has been the subject of several recalls since then.
Digital Health Roundup, May 2021: Immersive Technologies In Surgery Suite, ‘Smart’ Toilets And Pills, New SaMD Cybersecurity Standards
In this new roundup feature focusing on the most notable developments in digital health, we pick the key news from May.
In an interview, Elgar Fleisch, co-author of The Digital Pill, proselytized the benefits of digital health, explaining how particular innovations could solve problems in health care.